MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 592758 | Name: Amafolone

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Amafolone is a biochemical.

Chemical Structure

Amafolone
Amafolone
CAS#50588-47-1

Theoretical Analysis

MedKoo Cat#: 592758

Name: Amafolone

CAS#: 50588-47-1

Chemical Formula: C19H32ClNO2

Exact Mass: 341.2122

Molecular Weight: 341.92

Elemental Analysis: C, 66.74; H, 9.43; Cl, 10.37; N, 4.10; O, 9.36

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Amafolone;
IUPAC/Chemical Name
(2beta,3alpha,5alpha)-3-Amino-2-hydroxyandrostan-17-one, hydrochloride
InChi Key
NDDAQHROMJDMKS-XFYXLWKMSA-N
InChi Code
InChI=1S/C19H31NO2.ClH/c1-18-8-7-14-12(13(18)5-6-17(18)22)4-3-11-9-15(20)16(21)10-19(11,14)2;/h11-16,21H,3-10,20H2,1-2H3;1H/t11-,12-,13-,14-,15-,16-,18-,19-;/m0./s1
SMILES Code
C[C@]1([C@](CC2)([H])[C@]3([H])CC[C@@]4([H])C[C@H](N)[C@@H](O)C[C@]4(C)[C@@]3([H])CC1)C2=O.[H]Cl
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 341.92 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Borowicz LE, Martin CL, Sanguinetti MC. Cellular electrophysiological properties of a new aminosteroid antiarrhythmic agent, SC-35135. J Cardiovasc Pharmacol. 1988 Aug;12(2):218-26. PubMed PMID: 2459553. 2: Kane K, McDonald F, Parratt J, Timmer C, Vink J. Antiarrhythmic effects of Org 6001 in rats: correlation with plasma and tissue drug concentrations. Br J Pharmacol. 1982 Feb;75(2):319-23. PubMed PMID: 7186821; PubMed Central PMCID: PMC2071599. 3: Klein G, Wirtzfeld A, Schlegl J, Himmler C, Neiss A. [Efficacy of anti-arrhythmia agents]. Med Klin. 1980 Nov 21;75(24):853-5. German. PubMed PMID: 6160379. 4: Marshall RJ, Winslow E. The antidysrhythmic and cardiovascular effects of the aminosteroid, ORG 6001. Gen Pharmacol. 1981;12(5):315-22. Review. PubMed PMID: 7026350. 5: Kane KA. Comparative electrophysiological effects of Org 6001, a new orally active antidysrhythmic agent, and lignocaine on human ventricular muscle. Br J Pharmacol. 1980 Jan;68(1):25-31. PubMed PMID: 7357199; PubMed Central PMCID: PMC2044125. 6: Mokotoff M, Zhao M, Marshall RJ, Winslow E, Wong LK, Liao QJ. Peptidyl aminosteroids as potential new antiarrhythmic agents. Steroids. 1990 Sep;55(9):399-404. PubMed PMID: 2281517. 7: Marshall RJ, Muir AW, Winslow E. The effects of postligation administration of ORG 6001 and disopyramide on early ischaemia-induced arrhythmias in the anaesthetized rat. Br J Pharmacol. 1982 Aug;76(4):501-3. PubMed PMID: 7104520; PubMed Central PMCID: PMC2071817. 8: Au TL, Collins GA, Harvie CJ, Walker MJ. The actions of prostaglandins I2 and E2 on arrhythmias produced by coronary occlusion in the rat and dog. Prostaglandins. 1979 Nov;18(5):707-20. PubMed PMID: 396577. 9: Clark C, Foreman MI, Kane KA, McDonald FM, Parratt JR. Coronary artery ligation in anesthetized rats as a method for the production of experimental dysrhythmias and for the determination of infarct size. J Pharmacol Methods. 1980 Jun;3(4):357-68. PubMed PMID: 7392665. 10: Campbell TJ, Vaughan Williams EM. Electrophysiological and other effects on rabbit hearts of CCI22277, a new steroidal antiarrhythmic drug. Br J Pharmacol. 1982 Jun;76(2):337-45. PubMed PMID: 7093588; PubMed Central PMCID: PMC2071789. 11: Kane KA, Leprán I, McDonald FM, Parratt JR, Szekeres L. The effects of prolonged oral administration of a new antidysrhythmic drug (Org 6001) on coronary artery ligation dysrhythmias in conscious and anesthetized rats. J Cardiovasc Pharmacol. 1980 Jul-Aug;2(4):411-23. PubMed PMID: 6156339. 12: Vink J, van Hal HJ, Timmer CJ. Determination of nanogram amounts of the antiarrhythmic drug Org 6001 in biological fluids and tissues using selected ion monitoring. Biomed Mass Spectrom. 1980 Nov;7(11-12):592-6. PubMed PMID: 7225542. 13: Almotrefi AA, Baker JB. Antifibrillatory efficacy of encainide, loracainide and ORG 6001 compared with lignocaine in isolated hearts of rabbits and guinea-pigs. Br J Pharmacol. 1981 Jun;73(2):373-7. PubMed PMID: 6786403; PubMed Central PMCID: PMC2071657. 14: Marshall RJ, Muir AW, Winslow E. Comparative antidysrhythmic and haemodynamic effects of orally or intravenously administered mexiletine and ORG 6001 in the anaesthetized rat. Br J Pharmacol. 1981 Oct;74(2):381-8. PubMed PMID: 7317687; PubMed Central PMCID: PMC2071715. 15: Campbell TJ. Voltage- and time-dependent depression of maximum rate of depolarization of guinea-pig ventricular action potentials by two steroidal antiarrhythmic drugs, CCI 22277 and ORG 6001. Br J Pharmacol. 1982 Nov;77(3):541-8. PubMed PMID: 7139201; PubMed Central PMCID: PMC2044616. 16: Brown J, Marshall RJ, Winslow E. Effects of selective channel blocking agents on contractions and action potentials in K+-depolarized guinea-pig atria. Br J Pharmacol. 1985 Sep;86(1):7-17. PubMed PMID: 2413942; PubMed Central PMCID: PMC1916864. 17: Marshall RJ, Muir AW, Winslow E. Development of a severe model of early coronary artery ligation-induced dysrhythmias in the anaesthetized rat. Br J Pharmacol. 1981 Aug;73(4):951-9. PubMed PMID: 7272592; PubMed Central PMCID: PMC2071480.